Influence of Magnetic Resonance Contrast Media on the Activity of Histamine Inactivating Enzymes

Academic Radiology

Volumn 16, Issue 3, 2009, Pages 358-362

  Kuefner, Michael A ^a   Feurle, Johannes ^a   Uder, Michael ^a   Bautz, Werner ^a   Schwelberger, Hubert G ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Gadolinium based contrast media; histamine metabolism, diamine oxidase; histamine N methyltransferase; nephrogenic systemic fibrosis

Indexed keywords

AMINE OXIDASE (COPPER CONTAINING); AMINOGUANIDINE; AMODIAQUINE; CARBON 14; CONTRAST MEDIUM; ENZYME INHIBITOR; GADOBENATE DIMEGLUMINE; GADOBUTROL; GADODIAMIDE; GADOLINIUM; GADOLINIUM PENTETATE; GADOLINIUM PENTETATE MEGLUMINE; GADOTERATE MEGLUMINE; GADOTERIDOL; GADOXETIC ACID; HISTAMINE; HISTAMINE METHYLTRANSFERASE; MANGAFODIPIR; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; RECOMBINANT ENZYME; S ADENOSYLMETHIONINE;

ANALYZER; ARTICLE; CONTRAST ENHANCEMENT; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; FIBROGENESIS; HUMAN; IN VITRO STUDY; ISOTOPE LABELING; LIQUID SCINTILLATION COUNTING; NEPHROGENIC SYSTEMIC FIBROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIOMETRY;

AMINE OXIDASE (COPPER-CONTAINING); CONTRAST MEDIA; ENZYME ACTIVATION; GADOLINIUM; HISTAMINE; HISTAMINE N-METHYLTRANSFERASE; MAGNETIC RESONANCE IMAGING;

EID: 59449094474     PISSN: 10766332     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.acra.2008.09.005     Document Type: Article

References (30)

1. Heinrich M., and Uder M. Nephrogenic systemic fibrosis after application of gadolinium-based contrast agents-a status paper. Rofo 179 (2007) 613-617
2. Thomsen H.S., Morcos S.K., and Dawson P. Is there a causal relation between the administration of gadolinium based contrast media and the development of nephrogenic systemic fibrosis (NSF)?. Clin Radiol 61 (2006) 905-906
3. Sadowski E.A., Bennett L.K., Chan M.R., et al. Nephrogenic systemic fibrosis: risk factors and incidence estimation. Radiology 243 (2007) 148-157
4. Hough L.B. Genomics meets histamine receptors: new subtypes, new receptors. Mol Pharmacol 59 (2001) 415-419
5. Pearce F.L. Biological effects of histamine: an overview. Agents Actions 33 (1991) 4-7
6. Garbuzenko E., Nagler A., Pickholtz D., et al. Human mast cells stimulate fibroblast proliferation, collagen synthesis and lattice contraction: a direct role for mast cells in skin fibrosis. Clin Exp Allergy 32 (2002) 237-246
7. Baxter A.B., Lazarus S.C., and Brasch R.C. In vitro histamine release induced by magnetic resonance imaging and iodinated contrast media. Invest Radiol 28 (1993) 308-312
8. Maslinski C., and Fogel W.A. Catabolism of histamine. In: Uvnäs B. (Ed). Handbook of experimental pharmacology, vol. 97: histamine and histamine antagonists (1991), Springer, Berlin, Germany 165-189
9. Schwelberger H.G., Hittmair A., and Kohlwein S.D. Analysis of tissue and subcellular localization of mammalian diamine oxidase by confocal laser scanning fluorescence microscopy. Inflamm Res 47 suppl (1998) S60-S61
10. Schwelberger H.G. Diamine oxidase (DAO) enzyme and gene. In: Falus A. (Ed). Histamine: biology and medical aspects (2004), SpringMed, Budapest, Hungary 43-52
11. Hesterberg R., Sattler J., Lorenz W., et al. Histamine content, diamine oxidase activity and histamine methyltransferase activity in human tissues: fact or fictions?. Agents Actions 14 (1984) 325-334
12. Brown D.D., Tomchick R., and Axelrod J. The distribution and properties of a histamine-methylating enzyme. J Biol Chem 234 (1959) 2948-2950
13. Schwelberger H.G. Histamine N-methyltransferase (HNMT) enzyme and gene. In: Falus A. (Ed). Histamine: biology and medical aspects (2004), SpringMed, Budapest, Hungary 53-59
14. Pacifici G.M., Donatelli P., and Giuliani L. Histamine N-methyl transferase: inhibition by drugs. Br J Clin Pharmacol 34 (1992) 322-327
15. Sattler J., Hesterberg R., Lorenz W., et al. Inhibition of human and canine diamine oxidase by drugs used in an intensive care unit: relevance for clinical side effects?. Agents Actions 16 (1985) 91-94
16. Tachibana T., Taniguchi S., Imamura S., et al. Effects of drugs on the activity of histamine-N-methyltransferase from guinea pig skin. Biochem Pharmacol 37 (1988) 2872-2876
17. Maintz L., and Novak N. Histamine and histamine intolerance. Am J Clin Nutr 85 (2007) 1185-1196
18. Kusche J., Richter H., Hesterberg R., et al. Comparison of the 14-C-putrescine assay with the NADH test for the determination of diamine oxidase: description of a standard procedure with a high precision and an improved accuracy. Agents Actions 3 (1973) 148-156
19. Schwelberger H.G., Klocker J., Sattler J., et al. Determination of the activity of diamine oxidase in extremely small tissue samples. Inflamm Res 44 suppl (1995) S94-S95
20. Wilflingseder D., and Schwelberger H.G. Highly efficient purification of porcine diamine oxidase. J Chromatogr B Biomed Sci Appl 737 (2000) 161-166
21. Tamura H., Horiike K., Fukuda H., et al. Kinetic studies on the inhibition mechanism of diamine oxidase from porcine kidney by aminoguanidine. J Biochem 105 (1989) 299-306
22. Kufner M.A., Ulrich P., Raithel M., et al. Determination of histamine degradation capacity in extremely small human colon samples. Inflamm Res 50 suppl (2001) S96-S97
23. Huetz G.N., and Schwelberger H.G. Simultaneous purification of the histamine degrading enzymes diamine oxidase and histamine N-methyltransferase from the same tissue. Inflamm Res 52 suppl (2003) S65-S66
24. Barth H., Lorenz W., and Troidl H. Effect of amodiaquine on gastric histamine methyltransferase and on histamine-stimulated gastric secretion. Br J Pharmacol 55 (1975) 321-327
25. Falanga V., Soter N.A., Altman R.D., et al. Elevated plasma histamine levels in systemic sclerosis (scleroderma). Arch Dermatol 126 (1990) 336-338
26. Ennis M., Lorenz W., Nehring E., et al. In vitro and in vivo studies of radiographic contrast media-induced histamine release in pigs. Agents Actions 33 (1991) 26-29
27. Ennis M., Nehring E., and Schneider C. Adverse reactions to drugs: in vitro studies with isolated cells. Inflamm Res 53 suppl (2004) S105-S108
28. Laroche D. Immediate reactions to contrast media: mediator release and value of diagnostic testing. Toxicology 209 (2005) 193-194
29. Petersen J., Raithel M., and Schwelberger H.G. Characterisation of functional polymorphisms of the human diamine oxidase gene. Inflamm Res 54 suppl (2005) S58-S59
30. Preuss C.V., Wood T.C., Szumlanski C.L., et al. Human histamine N-methyltransferase pharmacogenetics: common genetic polymorphisms that alter activity. Mol Pharmacol 53 (1998) 708-717